NYSE$IFF
International Flavors & Fragra · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
IFF reported a 5% increase in sales and an EPS of $0.70 for the fourth quarter of 2019.
IFF reported a 5% increase in net sales to $1.28 billion for the fourth quarter of 2019. Reported EPS was $0.70, while adjusted EPS ex amortization was $1.46. The company continued to achieve significant cost synergies from Frutarom and captured solid year one revenue synergies.
- Delivered high-single digit currency neutral top-line growth.
- Achieved a robust double-digit increase in adjusted EPS ex amortization.
- Continued to achieve significant cost synergies from Frutarom well ahead of year-one targets.
- Captured solid year one revenue synergies, demonstrating broad operational strength.
Headline financials
Revenue & EPS history
IFF · Revenue · Quarterly
$1.28B
Revenue by segment
IFF · $908M total across 2 segments · Q4 2019
- Scent$478M—52.7%
- Taste$430M—47.3%
Forward guidance
The Company's 2020 guidance is as follows: Sales $5.15B - $5.35B, Adjusted EPS $4.89 - $5.14 and Adjusted EPS Ex Amortization $6.20 - $6.45.
Tailwinds
- Sales growth for 2020 is expected to be approximately 1% to 5% on a currency neutral basis.
- Excluding the impacts of the 53rd week in the prior year period and an anticipated 0.5 percentage point impact, principally related to the carryover effect from the Russia/Ukraine compliance issue and CitraSource, currency neutral core sales growth is expected to be approximately 2.5% to 6.5%.
- Adjusted EPS ex amortization growth for 2020 is expected to be approximately 3.5% to 7.5% on a currency neutral basis.
- Offsetting the negative impacts is a 6 percentage point contribution from integration synergies.
- The Company expects to achieve a Net Debt to EBITDA ratio of less than 3.0x by the end of 2020.
Headwinds
- Currency is expected to negatively impact sales by an estimated 1 percentage point, and adjusted EPS ex amortization by 3 percentage points.
- Sales growth for 2020 includes an estimated 1 percentage point impact related to the 53rd week in the prior year period and an anticipated 0.5 percentage point impact, principally related to the carryover effect from the Russia/Ukraine compliance issue and CitraSource.
- Adjusted EPS ex amortization growth for 2020 includes an estimated 5 percentage point impact related to an incentive compensation reset, an estimated 1 percentage point impact related to the 53rd week in the prior year period and an anticipated 0.5 percentage point impact, principally related to the carryover effect from the Russia/Ukraine compliance issue and CitraSource.
- The Company expects a modest impact from the recent coronavirus outbreak in Asia, based on its knowledge at this time.
- There are still too many variables and uncertainties regarding this outbreak to quantify currently.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2019
-0.6%
Avg return
Earnings day
-1.0%
Avg return
5 days after
-1.3%
Avg return
30 days after
56%
38 / 68 earnings
Positive
+11.0%
Q1 2026
Best reaction
-19.5%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.0% | +10.4% | +3.4% | |
| Q4 2025 | +5.9% | +7.5% | -9.6% | |
| Q3 2025 | +4.0% | +2.1% | +9.3% | |
| Q1 2025 | -7.0% | -3.6% | -2.9% | |
| Q4 2024 | -5.2% | -7.9% | -10.0% | |
| Q3 2024 | -11.5% | -6.8% | -10.1% | |
| Q2 2024 | -0.4% | +1.7% | +8.5% | |
| Q1 2024 | +8.9% | +12.2% | +13.2% | |
| Q4 2023 | -5.4% | -0.9% | +2.6% | |
| Q3 2023 | -1.5% | -1.3% | +4.1% | |
| Q2 2023 | -19.5% | -20.2% | -11.8% | |
| Q1 2023 | -6.4% | -13.8% | -15.8% | |
| Q4 2022 | -19.1% | -0.0% | -4.7% | |
| Q3 2022 | -3.6% | +6.0% | +14.0% | |
| Q2 2022 | -5.2% | -1.9% | -10.7% | |
| Q1 2022 | +2.7% | +8.2% | +8.8% | |
| Q4 2021 | +5.8% | +2.1% | -8.4% | |
| Q3 2021 | +6.6% | +6.3% | +3.2% | |
| Q2 2021 | +2.2% | +5.8% | +2.1% | |
| Q1 2021 | -5.3% | -3.6% | +0.4% | |
| Q4 2020 | +6.9% | +4.8% | +5.4% | |
| Q3 2020 | +3.6% | +3.3% | +6.1% | |
| Q2 2020 | -1.2% | -2.9% | -3.8% | |
| Q1 2020 | -0.8% | -4.6% | -0.7% | |
| Q4 2019 | -0.9% | -1.5% | -21.0% | |
| Q3 2019 | +10.4% | +9.1% | +15.0% | |
| Q2 2019 | -17.3% | -14.8% | -22.2% | |
| Q1 2019 | -3.5% | -2.7% | +0.9% | |
| Q4 2018 | -9.1% | -9.5% | -14.6% | |
| Q3 2018 | +1.9% | -0.1% | -5.3% | |
| Q2 2018 | +0.1% | -1.3% | -3.1% | |
| Q1 2018 | -11.0% | -10.2% | -11.6% | |
| Q4 2017 | +0.7% | -0.9% | -3.0% | |
| Q3 2017 | +1.1% | -1.0% | +3.7% | |
| Q2 2017 | +3.6% | +0.4% | +4.3% | |
| Q1 2017 | -7.4% | -6.1% | -1.0% | |
| Q4 2016 | +5.2% | +3.8% | +12.0% | |
| Q3 2016 | -2.0% | -8.0% | -3.1% | |
| Q2 2016 | +1.8% | +1.2% | +4.0% | |
| Q1 2016 | +6.5% | — | — | |
| Q4 2015 | -14.0% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -5.5% | — | — | |
| Q4 2014 | +9.3% | — | — | |
| Q3 2014 | -0.7% | — | — | |
| Q2 2014 | -3.8% | — | — | |
| Q1 2014 | +2.2% | — | — | |
| Q4 2013 | +4.1% | — | — | |
| Q3 2013 | +3.8% | — | — | |
| Q2 2013 | +0.5% | — | — | |
| Q1 2013 | +2.0% | — | — | |
| Q4 2012 | +3.4% | — | — | |
| Q3 2012 | -3.0% | — | — | |
| Q2 2012 | +8.0% | — | — | |
| Q1 2012 | -1.8% | — | — | |
| Q4 2011 | -1.0% | — | — | |
| Q3 2011 | -12.2% | — | — | |
| Q2 2011 | +0.9% | — | — | |
| Q1 2010 | +1.8% | — | — | |
| Q1 2011 | +0.9% | — | — | |
| Q4 2010 | +1.8% | — | — | |
| Q3 2010 | +4.9% | — | — | |
| Q3 2009 | +4.9% | — | — | |
| Q2 2009 | +2.1% | — | — | |
| Q4 2009 | +2.1% | — | — | |
| Q4 2008 | +2.1% | — | — | |
| Q2 2010 | +2.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro